SCHEMBL14881337

SCHEMBL14881337

Cc1cc2c(cc1-c1ccc(NC(=O)c3snnc3C)cc1)OC(F)(F)O2

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.53
▸ ORAI1 Q96D31 2/20 0.46
▸ TRPC3 Q13507 1/20 0.46
▸ TRPC5 Q9UL62 1/20 0.46
▸ ALDH1A1 P00352 3/20 0.46
▸ CRACR2A Q9BSW2 3/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ GAA P10253 2/20 0.43
▸ MEN1 O00255 2/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ POLB P06746 2/20 0.42
▸ USP2 O75604 1/20 0.41
▸ SCN9A Q15858 1/20 0.41
▸ STIM1 Q13586 1/20 0.41
▸ AGTR1 P30556 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ PKM P14618 1/20 0.40
▸ RAB9A P51151 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15986065 0.90 LMNA (0.51) LMNAORAI1TRPC3TRPC5ALDH1A1
SCHEMBL12181712 0.90 LMNA (0.51) LMNAORAI1TRPC3TRPC5ALDH1A1
SCHEMBL16019784 0.88 ABCC8 (0.42) LMNAORAI1SCN9ASTIM1
SCHEMBL16017275 0.83 RAB9A (0.53) ORAI1KDM4EMEN1KMT2APOLB
SCHEMBL14881327 0.83 KMT2A (0.47) ORAI1CRACR2AKMT2ASCN9ASTIM1
SCHEMBL16017233 0.81 STIM1 (0.44) ORAI1ALDH1A1MEN1KMT2ASCN9A
SCHEMBL14887577 0.80 HSD17B10 (0.55) LMNAORAI1ALDH1A1GAAMEN1
SCHEMBL16017208 0.79 MEN1 (0.56) ALDH1A1GAAMEN1KMT2APOLB
SCHEMBL14887583 0.79 SCN9A (0.43) ORAI1KMT2ASCN9ASTIM1
SCHEMBL16019777 0.79 ALDH1A1 (0.53) LMNAORAI1ALDH1A1KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140256771-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. 2014-09-11 — — US disclosed
US-20140256771-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. 2014-09-11 — — US disclosed
US-20140256771-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. 2014-09-11 — — US disclosed
EP-2768810-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM Calcimedica, Inc. (US) 2014-08-27 — — EP disclosed
WO-2013059666-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. (US) 2013-04-25 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140256771-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM ORAI1, SARAF, RYR2 LMNA 1306/4885ORAI1 1/4885TRPC3 39/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback